<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-19388</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Coexistent anti-glomerular basement membrane antibodies and anti-myeloperoxidasa antibodies in two patients with rapidly progressive glomerulonephritis</dc:title>
<dc:creator>Torre, A</dc:creator>
<dc:creator>Álvaro, F. de</dc:creator>
<dc:creator>Costero, O</dc:creator>
<dc:creator>Martínez Ara, J</dc:creator>
<dc:creator>Díaz Rodríguez, C</dc:creator>
<dc:creator>Gil, F</dc:creator>
<dc:creator>Picazo, M. L</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Grupo Aula Médica, S.A.</dc:publisher>
<dc:description xml:lang="es">Presentamos dos casos de insuficiencia renal rápidamente progresiva, sin hemorragia pulmonar. Las biopsias renales mostraron glomerulonefritis extracapilar con depósitos lineales de IgG. Serológicamente se evidenció positividad para anticuerpos antimembrana basal glomerular (Ac AMBG) y ANCA anti-mieloperoxidasa. A pesar del tratamiento con esteroides, ciclofosfamida y plasmaféresis, una paciente precisó hemodiálisis periódica y la otra falleció por complicaciones de la biopsia renal. Se discuten factores epidemiológicos, etipopatógenicos y pronósticos de la asociación (AU)</dc:description>
<dc:source>Nefrologia;22(2): 190-195, mar. 2002.</dc:source>
<dc:identifier>ibc-19388</dc:identifier>
<dc:title xml:lang="es">Presencia simultánea de anticuerpos anti-membrana basal glomerular y anticuerpos anti-mieloperoxidasa en dos pacientes con glomerulonefritis rápidamente progresiva</dc:title>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d6622</dc:subject>
<dc:subject>^d7853</dc:subject>
<dc:subject>^d29407</dc:subject>
<dc:subject>^d12604</dc:subject>
<dc:subject>^d30919</dc:subject>
<dc:subject>^d1507</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d1329</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d30693</dc:subject>
<dc:subject>^d3162</dc:subject>
<dc:subject>^d7344</dc:subject>
<dc:subject>^d31878</dc:subject>
<dc:subject>^d3540</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d22562</dc:subject>
<dc:subject>^d29510</dc:subject>
<dc:subject>^d22206</dc:subject>
<dc:subject>^d1731</dc:subject>
<dc:subject>^d1333</dc:subject>
<dc:subject>^d31474</dc:subject>
<dc:subject>^d1330</dc:subject>
<dc:subject>^d33077</dc:subject>
<dc:subject>^d32285</dc:subject>
<dc:subject>^d6065</dc:subject>
<dc:type>article</dc:type>
<dc:date>200203</dc:date>
</metadata>
</record>
</ibecs-document>
